These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of ifosfamide in the treatment of testicular and urothelial malignancies. Roth BJ Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497 [TBL] [Abstract][Full Text] [Related]
7. Ifosfamide in the treatment of small cell lung cancer. Ettinger DS Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443 [TBL] [Abstract][Full Text] [Related]
8. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer. Sandler AB Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210 [TBL] [Abstract][Full Text] [Related]
9. The role of ifosfamide in germ cell tumors and small cell lung cancer. Nichols CR Semin Oncol; 1995 Jun; 22(3 Suppl 7):13-7. PubMed ID: 7610394 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial. Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712 [TBL] [Abstract][Full Text] [Related]
11. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
13. Experience of a German multicenter study group with ifosfamide in small cell lung cancer. Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648 [TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
15. Chronic oral etoposide: trials at Indiana University and with the Hoosier Oncology Group. Loehrer PJ Semin Oncol; 1992 Dec; 19(6 Suppl 14):48-52. PubMed ID: 1336900 [TBL] [Abstract][Full Text] [Related]
16. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update. Ettinger DS Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538 [TBL] [Abstract][Full Text] [Related]
17. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer. Unsal M; Erturk D Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592 [TBL] [Abstract][Full Text] [Related]
19. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624 [TBL] [Abstract][Full Text] [Related]
20. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]